Association of Biotechnology Led Enterprises

News

DBT to fund Bharat Biotech to augment Covaxin capacity

Bharat Biotech, Haffkine Biopharma, Indian Immunologicals, and BIBCOL to enhance production of indigenous vaccine Covaxin. India aims to produce 10 crore (100 million) doses by September 2021.

Apr 16, 2021

By : Team ABLE

G S Krishnan takes over as new ABLE President

“ India’s BioPharmaceutical segment has played a commendable role in the discovery and manufacturing of COVID-19 vaccine during the pandemic and we need to build on this great momentum and lead the world in playing a critical role, identifying our capabilities,” said Mr Krishnan while taking over as the new ABLE President for 2021-24.

Apr 01, 2021

By : Team ABLE

Bharat Biotech, Biovet, Sapigen Biologix Signs Collaborative Research Agreemente with CSIR-IICT

Bharat Biotech International, Biovet, and Sapigen Biologix have signed a joint Master Collaborative Agreement (MCA) with CSIR-Indian Institute of Chemical Technology (CSIR-IICT) today, to collaborate on the development of novel platform technologies for Bio Therapeutics and vaccines to support the indigenous, affordable health care solutions for humans and animals

Mar 29, 2021

By : Team ABLE

Sea6 Energy granted patent on new Biostimulant product

India grants 1st Biostimulant patent to Sea6Energy

Mar 12, 2021

By : Sea6 Energy private limited

In Covid-19 pandemic budget, vaccines & healthcare get government attention

With substantial increase in the allocation for healthcare (137 % more) and special funds for Covid-19 vaccination drive, the Budget for 2021-22 presented by the Finance Minister Mrs Nirmala Sitharaman on February 1 has given a boost to many segments of the biotechnology industry

Feb 01, 2021

By : By Narayanan Suresh